Ethanol Extract of Cosmos caudatus Attenuates Oxidative Stress and Inflammation in a Testosterone-Induced Benign Prostatic Hyperplasia Rat Model via Reduction of Malondialdehyde, Interleukin-6, and Tumor-Infiltrating Lymphocytes Activity
Abstract
Benign Prostatic Hyperplasia (BPH) is a common age-related urological condition driven by chronic inflammation and oxidative stress, prompting the search for safer phytotherapeutic alternatives. This study evaluated the in vivo efficacy of ethanolic extract of Cosmos caudatus leaves in modulating the oxidative-inflammatory axis underlying testosterone-induced benign prostatic hyperplasia. Blood samples (0.5–1 mL) were collected from the retro-orbital plexus at baseline (T0), post-induction (T1), and post-treatment (T2) of thirty male Rattus norvegicus obtained from the Laboratory Animal Unit, Universitas Sebelas Maret, were allocated into five groups (n=6): Normal, Control, Positive Control receiving Finasteride, and treatment groups administered C. caudatus extract at 125 mg/kg or 250 mg/kg. BPH was induced using testosterone propionate (3 mg/kg/day, s.c.) for 28 days, followed by a 28-day treatment period. Serum malondialdehyde, interleukin-6, stromal tumor-infiltrating lymphocytes, prostate weight, and prostate index were evaluated. Testosterone induction significantly increased oxidative stress, systemic inflammation, and stromal lymphocytic infiltration, together with notable prostate enlargement (p<0.05). Treatment with both doses of C. caudatus extract markedly reduced malondialdehyde and interleukin-6 levels, suppressed tumor-infiltrating lymphocytes infiltration, and decreased prostate weight and prostate index compared with the untreated benign prostatic…
Read the paper
Related studies
- Treatment of non-metastatic castration-resistant prostate cancer: facing age-related comorbidities and drug–drug interactions
- The Efficacy of Flogofilm® in the Treatment of Chronic Bacterial Prostatitis as an Adjuvant to Antibiotic Therapy: A Randomized Prospective Trial
- Inhibition of growth and contraction in human prostate stromal cells by silencing of NUAK1 and -2, and by the presumed NUAK inhibitors HTH01-015 and WZ4003
- Effectiveness and Safety of a New Nutrient Fixed Combination Containing Pollen Extract Plus Teupolioside, in the Management of LUTS in Patients with Benign Prostatic Hypertrophy: A Pilot Study
- Extract from Cucurbita pepo improves BPH symptoms without affecting sexual function: a 24-month noninterventional study
- Aquablation vs. holmium laser enucleation of the prostate for benign prostatic hyperplasia: a 150-patients prospective comparative multicenter study
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.